No Data
Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
Biolife Solutions Insider Sold Shares Worth $882,110, According to a Recent SEC Filing
H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Cuts Target Price to $27
BioLife Solutions Is Maintained at Buy by HC Wainwright & Co.
Analyst Expectations For BioLife Solns's Future
BioLife Solutions: Strategic Refocus and Strong Q3 Performance Bolster Buy Rating With $27 Price Target